No coverage is required under §§ 58-17-100 to 58-17-106, inclusive, for the following:

(1) Any drug that has not been fully licensed or approved by the FDA;

(2) The use of any drug if the FDA has determined that use to be contraindicated; or

(3) Any experimental drug not otherwise approved for any indication by the FDA.

Source: SL 2000, ch 242, § 3.